Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.
The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring vascular health in the brain, improving blood flow and oxygenation. Impaired ...